This clinical-stage biotech develops innovative retinal disease therapies, with its lead candidate advancing through late-stage trials.

WASHINGTON — The National Academies of Sciences, Engineering, and Medicine’s New Voices in Sciences, Engineering, and Medicine program has announced its 2026-2028 cohort of members, a group of 20 ...

Gilead Sciences (GILD) is scheduled to announce Q1 earnings results on Thursday, May 7th, after market close. The consensus EPS Estimate is $1.91 (+5.5% Y/Y), and the consensus revenue estimate is $6.

The U.S. life sciences industry entered 2026 with surprising momentum, following threats of tariffs and disrupted trade, NIH funding cuts, and a sluggish IPO market. Accounting for more than ...

Nursing Clinical Professor Darci McCall is the first person from the College of Health Sciences to be named a Provost's ...